Back to Search
FREDERICK AHMANN MD
MD
Hematology & Oncology Physician
NPI: 1700857166Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
10449(AZ)
Research & Publications (7)
MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure.
PMID 18931824·Invest New Drugs·2009
3-trial
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
PMID 17308271·J Clin Oncol·2007
4-observational
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.
PMID 17308272·J Clin Oncol·2007
3-trial
Coccidioidomycosis of the prostate: a determination of incidence, report of 4 cases, and treatment recommendations.
PMID 15936822·J Infect·2006
5-case
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
PMID 14501381·Anticancer Drugs·2003
3-trial
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
PMID 14501380·Anticancer Drugs·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3838 N CAMPBELL AVE
TUCSON, AZ 85719 - Phone
- (520) 694-2873
Quick Facts
- NPI
- 1700857166
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile